BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Leukocyte
,
Hematopoietic cell
,
Lipitor
,
rs7903146
,
ZBTB7A
,
Angiogenesis
,
Obesity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
3 IV
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
NC1-Peptide From Collagen α3 (IV) Chains in the Basement Membrane of Testes Regulates Spermatogenesi…
LF-15 & T7, synthetic peptides derived from tumstatin, attenuate aspects of airway remodelling in a …
T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate …
Abnormal mRNA Splicing Effect of COL4A3 to COL4A5 Unclassified Variants.
Investigating the effect of bacteriophages on bacterial FtsZ localisation.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
3-day IV Antibiotic Treatment Versus 3-day IV Followed by 7-day Oral Antibiotic Treatment for AP in …
Evaluation of 3 Different Doses of IV Busulfan
Maxigesic IV Phase 3 Bunionectomy Study
Maxigesic® IV Phase 3 Exposure Study
A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ